Seeking Clues to DuPont de Nemours (DD) Q4 Earnings? A Peek Into Wall Street Projections for Key Metrics

06.02.25 15:15 Uhr

Werte in diesem Artikel
Aktien

74,09 EUR 0,51 EUR 0,69%

Indizes

6.061,5 PKT 23,6 PKT 0,39%

The upcoming report from DuPont de Nemours (DD) is expected to reveal quarterly earnings of $0.98 per share, indicating an increase of 12.6% compared to the year-ago period. Analysts forecast revenues of $3.07 billion, representing an increase of 5.8% year over year.The consensus EPS estimate for the quarter has been revised 3.5% lower over the last 30 days to the current level. This reflects how the analysts covering the stock have collectively reevaluated their initial estimates during this timeframe.Before a company reveals its earnings, it is vital to take into account any changes in earnings projections. These revisions play a pivotal role in predicting the possible reactions of investors toward the stock. Multiple empirical studies have consistently shown a strong association between trends in earnings estimates and the short-term price movements of a stock.While investors typically use consensus earnings and revenue estimates as indicators of quarterly business performance, exploring analysts' projections for specific key metrics can offer valuable insights.With that in mind, let's delve into the average projections of some DuPont de Nemours metrics that are commonly tracked and projected by analysts on Wall Street.The combined assessment of analysts suggests that 'Net Sales- Electronics & Industrial' will likely reach $1.50 billion. The estimate indicates a year-over-year change of +10.5%.According to the collective judgment of analysts, 'Net Sales- Corporate & Other' should come in at $232.58 million. The estimate indicates a year-over-year change of -10.6%.Based on the collective assessment of analysts, 'Net Sales- Water & Protection' should arrive at $1.35 billion. The estimate indicates a change of +5.6% from the prior-year quarter.Analysts predict that the 'Operating EBITDA- Electronics & Industrial' will reach $446.15 million. Compared to the present estimate, the company reported $378 million in the same quarter last year.Analysts expect 'Operating EBITDA- Corporate & Other' to come in at $4.00 million. Compared to the current estimate, the company reported $23 million in the same quarter of the previous year.The consensus among analysts is that 'Operating EBITDA- Water & Protection' will reach $339.98 million. Compared to the present estimate, the company reported $314 million in the same quarter last year.View all Key Company Metrics for DuPont de Nemours here>>>Shares of DuPont de Nemours have experienced a change of +3.6% in the past month compared to the +2.1% move of the Zacks S&P 500 composite. With a Zacks Rank #3 (Hold), DD is expected to mirror the overall market performance in the near future. You can see the complete list of today's Zacks Rank #1 (Strong Buy) stocks here >>>>7 Best Stocks for the Next 30 DaysJust released: Experts distill 7 elite stocks from the current list of 220 Zacks Rank #1 Strong Buys. They deem these tickers "Most Likely for Early Price Pops."Since 1988, the full list has beaten the market more than 2X over with an average gain of +24.3% per year. So be sure to give these hand picked 7 your immediate attention. See them now >>Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report DuPont de Nemours, Inc. (DD): Free Stock Analysis ReportTo read this article on Zacks.com click here.Zacks Investment ResearchWeiter zum vollständigen Artikel bei Zacks

Ausgewählte Hebelprodukte auf DuPont de Nemours

Mit Knock-outs können spekulative Anleger überproportional an Kursbewegungen partizipieren. Wählen Sie einfach den gewünschten Hebel und wir zeigen Ihnen passende Open-End Produkte auf DuPont de Nemours

NameHebelKOEmittent
NameHebelKOEmittent
Wer­bung

Quelle: Zacks

Nachrichten zu DuPont de Nemours

Wer­bung

Analysen zu DuPont de Nemours

DatumRatingAnalyst
04.10.2021DuPont de Nemours OverweightJP Morgan Chase & Co.
20.08.2019DowDuPont OutperformCowen and Company, LLC
25.06.2019DowDuPont NeutralMonness, Crespi, Hardt & Co.
10.06.2019DowDuPont OutperformCowen and Company, LLC
06.02.2019DowDuPont Market PerformCowen and Company, LLC
DatumRatingAnalyst
04.10.2021DuPont de Nemours OverweightJP Morgan Chase & Co.
20.08.2019DowDuPont OutperformCowen and Company, LLC
10.06.2019DowDuPont OutperformCowen and Company, LLC
12.10.2018DowDuPont buyDeutsche Bank AG
29.03.2018DowDuPont OutperformBMO Capital Markets
DatumRatingAnalyst
25.06.2019DowDuPont NeutralMonness, Crespi, Hardt & Co.
06.02.2019DowDuPont Market PerformCowen and Company, LLC
12.09.2017DowDuPont NeutralMonness, Crespi, Hardt & Co.
31.05.2017Dow Chemical Market PerformCowen and Company, LLC
26.04.2017DuPont (E I DuPont de Nemours and Sector PerformRBC Capital Markets
DatumRatingAnalyst
05.01.2009Dow Chemical verkaufenEuro am Sonntag
11.04.2007Dow Chemical verkaufenHamburger Sparkasse
03.02.2006Update Rohm and Haas Co.: ReduceUBS
07.07.2005Update Rohm and Haas Co.: SellLongbow

Um die Übersicht zu verbessern, haben Sie die Möglichkeit, die Analysen für DuPont de Nemours nach folgenden Kriterien zu filtern.

Alle: Alle Empfehlungen

Buy: Kaufempfehlungen wie z.B. "kaufen" oder "buy"
Hold: Halten-Empfehlungen wie z.B. "halten" oder "neutral"
Sell: Verkaufsempfehlungn wie z.B. "verkaufen" oder "reduce"